1. Signaling Pathways
  2. GPCR/G Protein
  3. Adenosine Receptor
  4. Adenosine Receptor Inhibitors

Adenosine Receptor Inhibitors

Adenosine A1 receptor (A1R)

Adenosine A2A receptor (A2AR)

Adenosine A2B receptor (A2BR)

Adenosine A3 receptor (A3R)

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

Adenosine Receptor Inhibitors, Agonists, Antagonists, Activators & Modulators
Product Name Adenosine A1 receptor (A1R) Adenosine A2A receptor (A2AR) Adenosine A2B receptor (A2BR) Adenosine A3 receptor (A3R) Purity
Inosine
A1AR
A2AR
    99.94%
ZM241385  
A2AR, Ki: 1.4 nM
    99.45%
Adenosine receptor agonist 2    
A2B, EC50: 0.38 nM
 
A2AAR antagonist 5
hA1AR, Ki: > 30000 nM
hA2AAR, IC50: 1863 nM
hA2AAR, Ki: 57 nM
hA2B, Ki: > 30000 nM
hA3, Ki: 358 nM
Adenosine 5'-monophosphate disodium    
A2BR
  99.63%
DPTN dihydrochloride      
hA3, Ki: 1.65 nM
98.47%
PSB-1115    
A2BR
  99.0%
Derenofylline
A1R, Ki: 1 nM
A2AR, Ki: 398 nM
 
Adenosine A3 receptor, Ki: 200 nM
99.93%
MIPS521
A1AR
      98.21%
FR194921
A1R, Ki: 6.6 nM
A2AR, Ki: 5400 nM
    98.10%
VUF-5574      
Recombinant Human Adenosine A3 receptor (A3R) , Ki: 4.03 nM
99.0%
ISAM-140    
hA2B, Ki: 3.49 nM
  99.85%
PSB36
rA1, Ki: 0.12 nM
rA2A, Ki: 552 nM
hA2B, Ki: 187 nM
hA3, Ki: 2300 nM
rA3, Ki: 6500 nM
99.0%
ANR94  
A2AR, Ki: 46 nM (human)
    98.91%
Adenosine receptor inhibitor 1
A1AR, Ki: >1000 nM
A2AR, Ki: 68.5 nM
hA2B, Ki: >1000 nM
Adenosine A3 receptor, Ki: >1000 nM
98.29%
(E)-8-(3-Chlorostyryl)caffeine  
A2AR
    99.4%
Sulcatone  
A2AR
    99.80%
M1069  
A2AR
A2BR
  98.04%
AB-MECA      
Adenosine A3 receptor
98.32%
2-Chloro-N-cyclopentyl-2′-C-methyladenosine
A1AR
      99.80%
Evodenoson  
A2AR
    99.74%
Adenosine receptor inhibitor 2
A1AR, Ki: 52.2 ± 8.5 nM
A2AR, Ki: 167 ± 22 nM
hA2B, Ki: >1000 nM
Adenosine A3 receptor, Ki: >1000 nM
99.08%
MRS1334
rA1, Ki: >100 nM
rA2A, Ki: >100 nM
 
hA3, Ki: 2.69 nM
98.93%
Adenosine receptor antagonist 2  
A2a adenosine receptor, IC50: 1 nM
A2b adenosine receptor, IC50: 3 nM
    99.37%
YT 146  
A2AR
    99.72%
LUF5834
A1R, Ki: 2.6 nM
A2AR, Ki: 28 nM
A2BR, EC50: 12 nM
  99.8%
A2AAR antagonist 2  
A2a adenosine receptor, IC50: 33.5 nM
    99.40%
MRE 0094  
A2A, Ki: 0.49 μM
A2B, Ki: 10 μM
  99.79%
A1AR antagonist 5
hA1AR, pKi: 6.11
hA2AAR, pKi: <4
   
A2AR-antagonist-1  
A2AR, IC50: 29 nM
   
A1AR antagonist 4
hA1AR, pKi: 6.29
hA2AAR, pKi: <4
   
hA2A/hCA XII modulator 1
hA1AR, Ki: 4.819 μM
hA2AAR, Ki: 6.4 nM
 
hA3, Ki: >30 μM
Adenosine receptor antagonist 1  
A2AR, IC50: 0.29 nM
   
A1/A3 AR antagonist 1
human A1, Ki: 36.7 nM
rat A1, Ki: 1.47 nM
   
human A3, Ki: 25.4 nM
A3AR modulator 1      
Adenosine A3 receptor
A3AR antagonist 3
hA1AR, Ki: 2.22 μM
hA2AAR, Ki: 7.73 μM
 
hA3, Ki: 37 nM
A3AR antagonist 1      
hA3, Ki: 4.63 nM
A2AR/A2BR antagonist 1  
A2AR, IC50: 11.2 nM
A2BR, IC50: 6.4 nM
 
A2A/A3 AR antagonist-1  
hA2AAR, Ki: 90 nM
 
hA3, Ki: 31.8 nM
A3AR agonist 4      
human A3, Ki: 1.24 nM
Naxifylline
rat A1, Ki: 0.67 nM
human A1, Ki: 0.45 nM
     
Neladenoson dalanate
A1R
     
A2A receptor antagonist 3
A1R, Ki: 107 nM
A2AR, Ki: 0.4 nM
A2BR, Ki: 37 nM
A3R, Ki: 1467 nM
ATL444
rA1, Ki: 7.0 nM
rA2A, Ki: 2.5 nM
A2BR, Ki: 61.8 nM
rA3, Ki: >1000 nM
SCH-202676      
Adenosine A3 receptor
MRS5698      
Adenosine A3 receptor, Ki: ~3 nM
Adenosine receptor antagonist 5      
human A3, Ki: 12 nM
LAS38096
A1, Ki: >1000 nM
A2A, Ki: >2500 nM
A2B, Ki: 17 nM
A3, Ki: >1000 nM
A2AAR antagonist 4
hA1AR, Ki: 286 nM
hA2AAR, Ki: 0.36 nM
hA2AAR, Kb: 1 nM
hA2B, Ki: 85.8 nM
hA3, Ki: 98.4 nM
A1AR antagonist 6
hA1AR, pKi: 7.13
hA2AAR, pKi: <4
   
Neladenoson dalanate hydrochloride
A1R
     
A2AR modulator-1  
A2AR, IC50: 9 nM
   
LJ-4517  
A2AR, Ki: 18.3 nM
   
PSB11 hydrochloride      
human A3, Ki: 2.3 nM
A3AR antagonist 2      
hA3, Ki: 4.54 nM
MRS3558  
hA2AAR, Ki: 0.6 nM
rA2A, Ki: 0.9 nM
   
A2AAR/HDAC-IN-1
A1AR, Ki: 503.3 ± 14 nM
A2AR, Ki: 163.5 ± 14 nM
hA2B, Ki: >10000 nM
Adenosine A3 receptor, Ki: >10000 nM
CP-608039      
Adenosine A3 receptor
hA3AR agonist 1      
Adenosine A3 receptor, Ki: 2.40 nM
A1AR antagonist 3
human A1, Ki: 9.69 nM
rat A1, Ki: 0.529 nM
     
VCP171
A1R
     
ST 1535  
A2a adenosine receptor
   
Adenosine receptor antagonist 6
A1, Ki: 392.23 nM
 
A2B, Ki: 2129 nM
A3, Ki: 9036 nM
A2A receptor antagonist 2  
A2AR, IC50: 8.3 nM
   
GW-493838
A1AR
     
VUF8504
human A1, Ki: 14 nM
   
human A3, Ki: 0.017 nM
Benzo[c][1,8]naphthyridin-6(5H)-one
hA1AR, Ki: 4.6 μM
hA2AAR, Ki: 4.8 μM
   
2-Chloro-3-deazaadenosine
A1, Ki: 0.3 μM
A2A, Ki: 0.08 μM
A2B, Ki: 25.5 μM
A3, Ki: 1.9 μM
MRS1067      
Adenosine A3 receptor
2-Hexynyl-5′-N-ethylcarboxamidoadenosine  
A2AR
   
CVT-2759 analog
A1, Ki: 167 nM
     
Adenosine receptor agonist 1      
hA3, Ki: 6.7 nM
GW 328267  
A2a adenosine receptor
   
FLAC6  
A2AR
   
CGH2466 dihydrochloride
A1, IC50: 19 nM
 
A2B, IC50: 21 nM
A3, IC50: 80 nM
CVT-5440
A1, Ki: >10,000 nM
A2A, Ki: >5,000 nM
A2B, Ki: 50 nM